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Abstract—We tested the hypothesis that transient receptor potential canonical type 3 (TRPC3) channels are increased in
vascular smooth muscle cells and aortic tissue from spontaneously hypertensive rats (SHR) compared with normotensive
Wistar Kyoto rats. Expression of TRPC3 was analyzed by immunohistochemistry and Western blotting. TRPC3 gene
knockdown was performed by specific small interfering RNA and TRPC3 overexpression using the pAdEasy-1 system.
Cytosolic calcium was measured using fluorescence spectrophotometry and vasoconstriction of aortic rings using a force
transducer. In SHR, the expression of TRPC3 channel protein was significantly higher in aortic rings (1.480.05 versus
1.000.06; each n6; P0.01) and vascular smooth muscle cells (1.280.08 versus 1.000.03; each n6; P0.05)
compared with Wistar Kyoto rats. Knockdown of TRPC3 gene expression by specific small interfering RNA
significantly reduced the angiotensin II–induced calcium influx by 303% (n6; P0.01), whereas TRPC3
overexpression significantly increased it by 553% (n6; P0.01). The angiotensin II–induced calcium increase was
significantly enhanced in vascular smooth muscle cells from SHR compared with Wistar Kyoto rats, even in the
presence of the calcium channel blocker amlodipine. Angiotensin II significantly elevated the TRPC3 channel protein
expression in vascular smooth muscle cells from SHR from 1.280.08 to 1.610.08 (each n6; P0.01). Angiotensin
II–induced TRPC3 expression was prevented by telmisartan. Administration of telmisartan to SHR for 4 weeks
significantly reduced blood pressure, angiotensin II–induced vasoconstriction, and TRPC3 channel protein expression
in aortic tissue. TRPC3 expression was not significantly reduced after reduction of blood pressure in SHR using
amlodipine. In conclusion, we give experimental evidence that increased TRPC3 channel protein expression in the
vasculature is important for elevated blood pressure. (Hypertension. 2009;53:70-76.)
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Transient receptor potential canonical (TRPC) are nonse-lective cation channels that had been identified in several
tissues, including heart and vascular smooth muscle cells
(VSMC). TRPC type 3 (TRPC3) channels play an important
role in several cardiovascular diseases and probably hyper-
tension.1–10 An increased TRPC3 expression could be
demonstrated in peripheral monocytes from spontaneously
hypertensive rats (SHR) compared with normotensive
Wistar Kyoto rats (WKY).5,6 Dietrich et al reported that
TRPC6 knockout mice showed elevated TRPC3 channel
expression, increased vasoconstriction, and increased
blood pressure.7 Increased angiotensin II–induced vasocon-
striction and proliferation of VSMC, as well as augmented
angiotensin II–induced intracellular signal transduction path-
ways and calcium influx, have frequently been observed in
primary hypertension.6,11–15 Part of the action of angiotensin
II may occur through TRPC channels. Although data from the
literature gave evidence that calcium influx through TRPC3
channels may contribute to vasoconstriction and hyperten-
sion, this has not been tested yet using VSMC from SHR. In
the present study, we tested the hypothesis that calcium influx
through TRPC3 is increased in VSMC and aortic tissue from
SHR compared with WKY.
Methods
A detailed description of the Methods can be found in an online
supplement available at http://hyper.ahajournals.org.
Animals (SHR and WKY), interventions and hemodynamic mea-
surements, preparation of aortic rings and vasoconstriction,16,17
culture of VSMC, measurements of cytosolic calcium concentra-
tion,18,19 RNA isolation and RT-PCR, and immunoblottings and
immunohistochemistry had been described previously by our group.
All experiments were performed as approved by the animal care and
use committee. The TRP channel blocker SKF-96365 (Merck Bio-
sciences; final concentration 10 mol/L) was used.20–22 Changes of
cytosolic calcium were reported as described.23 Antibodies were
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purchased from Alomone Labs (Jerusalem, Israel),5,24,25 or Santa
Cruz Biotechnology (Santa Cruz, Calif). Small interfering RNA knock-
down was performed using silencer small interfering RNA transfection
kit (Ambion; Austin, Tex). Overexpression of TRPC3 channels was
done using pAdEasy-1 system.
Statistical Analysis
All results are expressed as the meanSEM of 3 independent
experiments. Data were compared using 2-tailed Student t test or
ANOVA and Tukey’s multiple comparisons post hoc test as appro-
priate. Two-sided P values 0.05 were considered significant.
Where error bars do not appear on the figures, error was within the
symbol size.
Results
Identification of TRPC in the Vasculature
First, we used RT-PCR to show the presence of TRPC3
transcripts in vasculature from adult normotensive WKY,
5-week-old prehypertensive SHR (preSHR), and adult SHR.
Calculating the TRPC3/GAPDH ratio indicated that TRPC3
transcripts were significantly more expressed in vasculature
from adult SHR compared with adult WKY or preSHR (each
P0.05; Figure 1A).
Second, we identified TRPC3 channel proteins in VSMC
from SHR and normotensive WKY using specific antibodies
and immunohistochemistry (Figure 1B).
Increased Expression of TRPC3 Channel Protein
in Aortic Tissue From SHR
Systolic blood pressure was 1966 mm Hg in adult SHR and
1094 mm Hg in adult WKY (each n6; P0.05). Body
weight was 32913 g in SHR and 32611 g in WKY. The
expression of TRPC3 channel protein was significantly ele-
vated in aortic tissue (1.480.05 versus 1.000.06; each
n6; P0.01; Figure 2A) from SHR compared with WKY.
In contrast, the expression of angiotensin II type 1 receptor
(AT1R) protein was not significantly different in aortic rings
from SHR and WKY (1.130.03 versus 1.000.06; each
n6; PNS; Figure 2B).
Increased Expression of TRPC3 Channel Protein
in VSMC From SHR
The expression of TRPC3 channel protein was significantly
elevated in VSMC from SHR compared with WKY
(1.280.08 versus 1.000.03; each n6; P0.05; Figure
2C). In contrast, the expression of AT1R protein was not
significantly different in VSMC from SHR and WKY
(1.140.06 versus 1.000.05; each n6; P0.05; Figure
2D). In additional experiments, we established that TRPC3
channel protein expression was not affected by cell culture by
comparing TRPC3 channel protein expression in freshly
isolated cells and cultured VSMC from the third and tenth
passage. As shown in Figure 2E for WKY (freshly isolated
cells 1.050.12; third passage 1.090.05; tenth passage
1.060.06; each n3; PNS) and Figure 2F for SHR
(freshly isolated cells 1.220.10; third passage 1.270.07;
tenth passage 1.210.11; each n3; PNS), TRPC3 channel
protein expression was not affected by cell culture.
As indicated in Figure 2G and 2H, both systolic blood
pressure and the expression of TRPC3 channel protein in
aortic tissue from adult SHR were significantly higher com-
pared with 5-week-old preSHR or with adult WKY.
Now, we investigated whether the increased TRPC3 chan-
nel protein expression in SHR was associated with enhanced
angiotensin II–induced elevation of blood pressure, vasocon-
striction, and calcium increase in SHR. The intravenous
injection of angiotensin II at a rate of 24 g/kg per hour for
60 minutes increased mean arterial blood pressure in rats. The
angiotensin II–induced elevation of arterial blood pressure
was significantly higher in SHR compared with WKY
(533 mm Hg versus 224 mm Hg; each n6; P0.05).
Furthermore, angiotensin II–induced aortic contraction was
significantly higher in SHR compared with WKY (823% of
maximal potassium contraction versus 546% of maximum
potassium contraction; each n6; P0.01). Additional ex-
periments showed that compared with control conditions
(1008%; n12), the administration of calcium channel
blocker amlodipine significantly reduced the angiotensin
II–induced contraction to 727% (n9; P0.05), whereas
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Figure 1. A, Representative polymerase chain reaction products
from mRNA of TRPC3 genes in vasculature from adult normo-
tensive WKY, 5-week-old preSHR, and adult SHR. The
expected product size for TRPC3 was 442 bp. M denotes
marker (bp ladder). The TRPC3/GAPDH ratio was significantly
higher in adult SHR compared with adult WKY or preSHR (each
n3; *P0.05 by ANOVA and Tukey’s multiple comparisons
post hoc test). Error bars are SEM. B, Light microscopy of
VSMC and immunohistochemistry of TRPC3 channel protein in
VSMC from SHR (left panels) and from WKY (middle panels).
Immunohistochemistry using specific antibodies labeled with
green shows an increased TRPC3 expression in VSMC from
SHR compared with WKY. Control indicates that primary anti-
bodies were preincubated for 12 hours at 4°C with antigenic
peptide. Magnification, 200.
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the administration of TRP cation channel blocker SKF-96365
significantly reduced it to 183% (n7; P0.05 by ANOVA
and Tukey’s multiple comparisons post hoc test; Figure 3A). As
indicated in Figure 3A, the angiotensin II–induced aortic
contraction was also significantly higher in SHR compared
with WKY in the presence of amlodipine but not in the
presence of SKF-96365.
Baseline cytosolic calcium concentration was similar in
VSMC from SHR and WKY (10312 versus 999 nmol/L,
respectively; each n6; PNS).
The angiotensin II–induced calcium increase was signifi-
cantly enhanced in VSMC from SHR compared with WKY
(increase of cytosolic calcium 22910 versus 11513
nmol/L, respectively; P0.01). In the presence of calcium
channel blocker amlodipine, the angiotensin II–induced cal-
cium influx was still significantly higher in VSMC from
SHR compared with WKY (17010 versus 13012 nmol/L,
respectively; P0.01). In contrast, in the presence of the TRP
cation channel blocker SKF-96365, the angiotensin II–
calcium-influx was similar in VSMC from SHR and WKY
(12613 versus 11310 nmol/L, respectively; PNS by
ANOVA and Tukey’s multiple comparisons post hoc test;
Figure 3B).
Using TRPC3 channel protein overexpression, we con-
firmed that an increased TRPC3 channel protein expression
in VSMC caused elevated angiotensin II–induced calcium
influx, whereas TRPC3 gene knockdown in VSMC reduced
TRPC3 expression and caused reduced angiotensin II–induced
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Figure 2. Increased expression of TRPC3 channel protein in aortic tissue and VSMC from SHR. Representative Western blotting and
summary data of TRPC3 channel protein or AT1R protein expression in aortic tissue (A and B) or VSMC (C and D) from WKY (open
bars) and SHR (filled bars). Data are meanSEM of n6 independent experiments. **P0.01. Expression of TRPC3 channel protein
was compared in freshly isolated cells (freshly) and cultured VSMC from WKY (E) and SHR (F), the third and tenth passage, respec-
tively. Data are meanSEM of n3 independent experiments. Systolic blood pressure (G) and expression of TRPC3 channel protein in
aortic tissue (H) from adult normotensive WKY (open bars), 5-week-old preSHR (hatched bars), and adult SHR (filled bars). Data are
meanSEM of n3 independent experiments. *P0.05 by ANOVA and Tukey’s multiple comparisons post hoc test.
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calcium influx. Transfecting TRPC3 gene into cultured VSMC
from SHR significantly increased TRPC3 channel protein ex-
pression from 1004% to 1674% (n6; P0.01; Figure 4A)
and hence significantly elevated the angiotensin II–induced
calcium increase by 554% (n6; P0.01; Figure 4B).
Specific small interfering RNA against TRPC3 signifi-
cantly reduced TRPC3 channel protein expression in cultured
VSMC from SHR from 10011% to 494% (n3; P0.05;
Figure 4C), whereas TRPC6 channel protein expression was
not affected (10018% versus 9916%; PNS; Figure 4D).
The reduction of TRPC3 channel protein expression in
VSMC significantly reduced the angiotensin II–induced cal-
cium increase by 363% (n5; P0.05; Figure 4E).
Next, we determined whether angiotensin directly in-
creases the expression of TRPC3 channel protein in VSMC.
To this end, VSMC from SHR or WKY were cultured in the
continuous presence of 100 nmol/L angiotensin II throughout
culturing. The administration of angiotensin II significantly
elevated the expression of TRPC3 channel protein in VSMC
from SHR from 1.280.08 to 1.610.08 (each n6;
P0.01) but only slightly changed TRPC3 channel protein
expression in VSMC from WKY from 1.000.03 to
1.110.07 (each n6; PNS; Figure 5A). As indicated in
Figure 5B, the administration of the AT1R antagonist
telmisartan prevented the angiotensin II–induced TRPC3
channel protein expression in VSMC from SHR (0.740.05
versus 1.610.08; each n6; P0.01).
These data indicated that angiotensin II increased the
expression of TRPC3 channel protein in VSMC from SHR in
vitro, and this effect could be blocked by the AT1R antago-
nist telmisartan. Now, we investigated whether the effects of
telmisartan on TRPC3 channel protein expression could also
be observed in vivo. To support the hypothesis that block-
ing of angiotensin II but not reduction of blood pressure
per se affects TRPC3 channel protein expression in
VSMC, we also used the calcium channel blocker amlo-
dipine in SHR. SHR were randomly allocated to placebo,
telmisartan (5 mg/kg per day), or amlodipine (10 mg/kg
per day), which was administered for 4 weeks. Compared
with placebo (2015 mm Hg; n6), the administration of
telmisartan significantly reduced blood pressure to
1248 mm Hg (n6), whereas amlodipine significantly
reduced blood pressure to 1165 mmHg (n5; each
P0.01 compared with placebo by ANOVA and Tukey’s
multiple comparisons post hoc test; Figure 6A). Furthermore,
the angiotensin II–induced vasoconstriction of aortic rings
was significantly lower in the telmisartan group compared
with the placebo group (308% versus 823%; each n6;
P0.01). Most important, compared with placebo, telmisar-
tan significantly reduced TRPC3 channel protein expression
from 1.000.07 to 0.320.20 (each n3; P0.05 by
ANOVA and Tukey’s multiple comparisons post hoc test),
whereas TRPC3 channel protein expression was unchanged in
the amlodipine group (1.300.15; n3; PNS; Figure 6B).
Discussion
This report is the first to give experimental evidence for the
importance of increased TRPC3 channel protein expression
in the vasculature for elevated blood pressure in SHR.
Foremost, for the first time, our present study showed an
increased TRPC3 channel protein expression in the vascula-
ture from adult SHR compared with adult WKY. In line with
these findings, we observed increased TRPC3 transcripts in
the vasculature from SHR compared with WKY. Further-
more, we showed that TRPC3 channel protein expression in
the vasculature from 5-week-old prehypertensive SHR was
similar to normotensive WKY. Second, for the first time, this
study reported that TRPC3 channel proteins are regulated by
angiotensin II in VSMC from SHR. Third, for the first time,
this study showed that the long-term administration of telm-
isartan (but not amlodipine) to hypertensive rats reduces
TRPC3 channel protein expression, confirming the impor-
tance of TRPC3 channel protein regulation by angiotensin II
in vivo as well. However, additional electrophysiological data
are needed to support these results.
The increased expression of TRPC3 was associated with
enhanced angiotensin II–induced elevation of blood pressure,
enhanced angiotensin II–induced vasoconstriction, and en-
hanced angiotensin II–induced calcium influx in VSMC from
SHR. The hyper-responsiveness of vessels and VSMC from
SHR after angiotensin II stimulation has been demonstrated
clearly by several groups.6,12–15 Our present findings support
previous results from several groups showing an increased
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Figure 3. A, Angiotensin II–induced contraction in aorta from
SHR (filled bars) or WKY (open bars) under control conditions
(Control), after administration of the calcium channel blocker
amlodipine (Amlo), or after administration of TRP cation channel
blocker SKF-96365 (SKF). *P0.05 by ANOVA and Tukey’s mul-
tiple comparisons post hoc test. B, Angiotensin II–induced cal-
cium increased in VSMC from SHR (filled bars) compared with
WKY (open bars) under Control, after administration of Amlo, or
after administration of SKF. **P0.01 for comparison of indi-
cated groups by ANOVA and Tukey’s multiple comparisons post
hoc test. Error bars are SEM.
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angiotensin II–induced calcium influx in VSMC from
SHR.12–15 Although major calcium influx in VSMC is medi-
ated by voltage-gated calcium channels, TRPC channels are
important signal transducers for agonist-mediated vascular
contractility. It should be noted that the increased angiotensin
II–induced calcium influx in primary hypertension could also
be observed in the presence of the calcium channel blocker
amlodipine. On the other hand, in the presence of the nonselec-
tive TRP cation channel blocker SKF-96365, the angiotensin
II–induced calcium influx was similar in VSMC from SHR
and WKY. Furthermore, in SHR, the angiotensin II–induced
calcium influx was considerably more reduced in the pres-
ence of SKF-96365 compared with amlodipine, supporting an
important role of calcium influx through TRP channels in
SHR. Use of SKF-96365 has been validated to block TRP
cation channels by several investigators.20–22 SHR is a well-
known animal model of hypertension showing no significant
differences of AT1R expression compared with WKY.26–28
We gave experimental evidence that TRPC3 channels are
directly involved in angiotensin II–induced calcium influx.
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TRPC3 overexpression in VSMC increased the angiotensin
II–induced calcium influx, whereas TRPC3 gene knockdown
reduced angiotensin II–induced calcium influx in VSMC. In
accordance with these results, Kaznacheyeva et al recently
showed that downregulation of TRPC3 reduces calcium
influx after depletion of intracellular stores in A431 cells.29
Second, the administration of angiotensin II significantly
elevated the expression of TRPC3 in VSMC from SHR but
not from WKY, supporting the proliferative action of angio-
tensin II in hypertension. Third, the administration of the
AT1R antagonist telmisartan prevented the angiotensin II–
induced elevation of TRPC3 expression in cultured VSMC
from SHR in vitro. Long-term administration of telmisartan
significantly reduced blood pressure, vasoconstriction, and
most important, TRPC3 expression, in aortic tissue in vivo.
On the other hand, we showed that the reduction of blood
pressure using amlodipine did not significantly change
TRPC3 expression in vasculature. In line with these results,
Kogata et al reported that long-term treatment with telmisar-
tan but not amlodipine improved the acetylcholine-induced
vessel relaxation in hypertensive rats, although blood pres-
sure reduction was similar in both groups.30 The observed
reduction of TRPC3 after administration of telmisartan but
not amlodipine may also explain in part the protective effects
of AT1 antagonists in hypertension beyond blood pressure
reduction as indicated by recent literature. The AT1 receptor
antagonists irbesartan and candesartan but not amlodipine
treatment showed beneficial effects in diabetic apolipoprotein
E–null mouse or monkeys.31–32
Perspectives
We observed an increased TRPC3 cation channel expression
in vasculature from SHR compared with WKY, which was
associated with increased contraction, an increased angioten-
sin II–induced TRPC3 expression, and finally, the reduction
of TRPC3 expression after administration of telmisartan but
not amlodipine in vivo. These results add to a considerable
body of evidence that TRP channels are involved in vaso-
regulatory mechanisms.33 Furthermore, the present results
point to the relevance of TRPC3 in the pathogenesis of
primary hypertension. As indicated by recent literature, ex-
pression of several TRP channel subtypes may be divergent
and redundant in cardiovascular diseases. Moreover, TRP
channels display diverse properties, localization, and regula-
tion as a result of their assembly into distinct homomeric and
heteromeric channel complexes.34 However, TRP channels
will be fascinating targets to elucidate novel pathogenic
mechanisms in hypertension, and TRP channels will be new
therapeutic targets for cure of hypertension.
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Methods 
 
Animals, interventions and hemodynamic measurements 
Male 3-month-old SHR and WKY were housed under a 12h/12h day/night cycle. Some 
experiments were performed in 5-weeks-old prehypertensive SHR. Rats were obtained from 
Charles Rivers Laboratories and fed with standard chow and had water ad libitum. All 
experiments were performed as approved by the Animal Care and Use Committee. 
Hemodynamic measurements were done as described in the literature.1,2 Rats were 
anesthetized with pentobarbital sodium (60mg/kg IP). While rats were breathing 
spontaneously, the right carotid artery was cannulated for measurements of arterial blood 
pressure with a pressure transducer (model MLT 1030, Power Lab, Australia). The left 
jugular vein was cannulated for IV infusion of angiotensin II (24µg/kg/h). Infusion with 
angiotensin II was performed for 60 minutes. 
The effect of long term administration of the angiotensin II receptor 1 (AT1R) antagonist 
telmisartan or the calcium channel blocker amlodipine on blood pressure and TRPC3 
expression was investigated in SHR. SHR were randomly allocated to the groups. Telmisartan 
(5mg/kg/day), amlodipine (10mg/kg/day), or placebo was given by gavage for 4 weeks. 
Systolic blood pressure which was measured by tail-cuff plethysmography and body weights 
were quantified every week. At the end of 4 weeks, the rats were killed by decapitation and 
aorta was used for measurements. 
 
Preparation of aortic rings and vasoconstriction 
The thoracic aorta was dissected, carefully freed from connective tissue, and placed in Krebs 
solution, containing (in mmol/L) NaCl 120, CaCl2 2.5, KCl 5.6, MgSO4 1.2, NaHCO3 25, 
NaH2PO4 1.2, D-glucose 5.5, equilibrated with 95% O2/5% CO2, pH 7.4 at 37°C. After 
careful removal of endothelial layer isometric force of the aortic rings was measured 
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according to established methods using a force transducer connected with a polygraph (model 
AD Instrument, Power Lab) as described by our group.1 The aortic rings were equilibrated for 
60minutes. The resting tension was set to 2g. Angiotensin II (100nmol/L) was added and the 
contractions of the rings were measured. Data were given relative to maximum potassium 
contraction. 
 
Culture of vascular smooth muscle cells  
VSMC were obtained from thoracic aortas and cultured by tissue explant method as 
described.3,4 VSMC were grown in Dulbecco modified Eagle medium (DMEM) 
supplemented with 10% fetal calf serum, 2mmol/L glutamine, 50U/mL penicillin G, and 
50µg/mL streptomycin. Cultures were maintained at 37°C in a humidified atmosphere of 95% 
air/5% CO2. Cells were made quiescent by incubation of 95%-confluent cell cultures in 
serum-free DMEM/F12 (1:1) containing 15mmol/L N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid (HEPES), pH7.4, 0.1% bovine serum albumin, and 5µg/mL transferrin for 
48h. In additional experiments VSMC from SHR or WKY were cultured in the continuous 
presence of 100nmol/L angiotensin II. To verify that cultured cells were VSMCs, 
immunocytochemical localization of smooth muscle-specific α-actin was performed using 
monoclonal antibodies ASM-1 raised against smooth muscle α-actin. A viability of VSMC 
more than 95% was observed by trypan blue exclusion. 
  
Measurement of cytosolic calcium concentration 
Cytosolic calcium concentration was measured in cultured VSMC using the fluorescent dye 
technique as previously described by our group.3,4 VSMC were loaded with 2µmol/L of the 
calcium-sensitive, cell permeable, intracellular fluorescence dye fura2/AM (Sigma-Aldrich, 
USA) at room temperature for 60minutes and washed to remove extraneous dye. Fluorescence 
was measured at 510nm emission with excitation wavelengths of 340nm and 380nm, and 
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fluorescence excitation ratio was calculated. Additional experiments were performed in the 
presence of the calcium channel blocker amlodipine or 1-[ß-[3-(4-methoxyphenyl) propoxy]-
4-methoxyphenethyl]-1H-imidazole (SKF-96365; Merck Biosciences; final concentration, 
10µmol/L), which has been reported to block non-selective TRP cation channels by several 
investigators.5-7 As indicated by recent literature data on angiotensin II-induced calcium 
increase are expressed as differences in cytosolic calcium from baseline in nmol/L.8 
 
RNA isolation and reverse transcription polymerase chain reaction (RT-PCR） 
Total RNA was isolated from aortic tissue of adult normotensive Wistar Kyoto rats (WKY), 
5-weeks-old prehypertensive spontaneously hypertensive rats (preSHR), and adult 
spontaneously hypertensive rats (SHR) using TRIzol reagent (Invitrogen, USA). RNA was 
used to synthesize first-strand cDNA using the Reverse Transcription System (Promega 
A3500, USA). 2.5μg total mRNA was reverse-transcribed with a reverse transcription mixture 
consisting of oligo dT and 15 U AMV reverse transcriptase at 42Ԩ for 60 min, followed by 
heating to 95Ԩ for 5 min. 3μl of 1:3 diluted single-stranded cDNA was added to 25μl PCR 
mix and amplified using 2xTaq Plus PCR MasterMix (Tiangen Biotech CO, PR China). PCR 
was started with denaturation at 95Ԩ for 5 min, then 34 cycles were performed under the 
following conditions: denaturation at 95Ԩ for 40s, annealing at 60Ԩ for 30s, and extension at 
72Ԩ for 40s. The sense and antisense primers for coding regions of TRPC3 or 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were the following: 
TRPC3（NM_021771) Forward 5'-CTGGCACAAATGTGGGCAATA-3'; 
Reverse 5'-GCGTTCGGATGAGAAGGTAGG-3'; 
GAPDH (NM_017008) Forward 5'- ACGGCAAATTCAACGGCACAGTCA -3'; 
Reverse 5'-TGGGGGCATCGGCAG AAGG-3'. 
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The PCR products were size fractionated on 1.5% agarose gels, and DNA was visualized by 
ethidium bromide staining using an imaging analyzer (GelDoc 2000，BioRad，Germany). 
The expected product sizes were 442bp for TRPC3 and 231bp for GAPDH, respectively. 
 
Western blotting 
Immunoblottings of TRPC3 and AT1R were performed using standard techniques.4 Quiescent 
VSMC grown on culture plates were exposed to Hanks balanced salt solution for control or 
angiotensin II at a final concentration of 100nmol/L for 24 hours VSMC were homogenized 
in high-salt buffer containing NaCl 600mmol/L, MOPS 40mmol/L, DTT 1mmol/L, leupeptin 
1µg/mL, aprotinin 1µg/mL, phenylmethylsulfonyl fluoride 50mmol/L. Cells were scraped off, 
transferred to Eppendorf tubes, and sonicated for 5seconds. The protein supernatant was 
separated by centrifugation, and protein concentrations were determined with Bio-Rad protein 
assay reagent (Bio-Rad Laboratories, USA). Proteins were separated by using 10% sodium 
dodecyl sulfate polyacrylamide gel and transferred to Hybond-ECL nitrocellulose membranes 
(NEN Life Science Products, Boston, USA) at 100V for 1hour. Membranes were blocked 
with blocking buffer containing tromethamine hydrochloride–buffered saline and 0.1% 
polysorbate-20 with 5% wt/vol nonfat dry milk and incubated for 8hours at 4°C. Membranes 
were incubated with primary rabbit anti-TRPC3 antibody (alomone Labs, Jerusalem, Israel), 
which had been used by several investigators,9,10 or rabbit polyclonal IgG anti-AT1-Receptor 
(Santa Cruz Biotechnology, USA) diluted 1:1000 for 8hours at 4°C. After washing 
membranes were incubated with secondary antibodies (goat anti-rabbit horseradish 
peroxidease) diluted 1:2000 for 1hour at room temperature, and washed extensively. Each 
sample was processed three times. The data for TRPC expression in SHR were normalized to 
the expression in WKY. 
 
Knockdown of TRPC3 gene expression using small interfering RNA 
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RNA interference for the down-regulation of a specific gene in living cells by small 
interfering RNA (siRNA) was performed. VSMCs were transfected with siRNA specific for 
TRPC3 for 24 hours using a silencer siRNA transfection kit (Ambion, Austin, USA) or with 
negative control siRNA. Briefly, VSMCs were resuspended in advanced Dubecco’s modified 
Eagle’s medium containing 10% fetal bovine serum and incubated with siPORT amine 
(Ambion) and 1µL chemically synthesized siRNA (final concentration, 20nmol/L; Ambion) 
specific for the TRPC3 channel. The target sequence for TRPC3 was 5’–
GGUUAAACCUCUUCACUCAtt–3’ (sense) and 5’– UGAGUGAAGAGGUUUAACCtg–3’ 
(antisense), respectively. 
 
Over-expression of TRPC3 using pAdEasy-1 system 
The cDNA encoding human TRPC3 was amplified by RT-PCR from TRPC3pcDNA3. 
Recombined shuttle plasmid pAdTrack-CMV-TRPC3 was constructed by linking the 
pAdTrack-CMV with the TRPC3 and was sequenced. For generation of recombinant 
adenoviral plasmids, pAdTrack-CMV-TRPC3 was linearized with PmeI, and was transformed 
into electrocompetent E. coli BJ5183 cells which contained adenoviral backbone vectors 
(pAdEasy-1). Clones showing inserts were screened by restriction endonuclease digestions. 
For production of adenoviruses in HEK293 cells, recombinant adenoviral plasmid DNA, 
digested with PacI and purificated by gel extraction kit, were used for transfection of HEK293 
cells. Transfected cells were monitored for green fluorescent protein (GFP) expression and 
collected 7–10 days after transfection by scraping cells off flasks and pelleting them along 
with any floating cells in the culture. After three cycles of freezing in a methanoly dry ice 
bath and rapid thawing at 37°C, viral lysate was used to infect VSMC in flasks. 
 
Immunohistochemistry 
7 
 
Cultured VSMC were fixed with 10% formalin for 10minutes at room temperature, washed 
with phosphate buffered saline (PBS) and then permeabilized with PBS containing 0.5% 
Triton X-100 for 20 minutes at room temperature. VSMC were incubated with PBS 
containing with 5% bovine serum and 0.1% Triton X-100 for 1hour at room temperature. 
Then VSMC were incubated with rabbit anti-TRPC3 antibody (1:200, alomone) over night at 
4°C. VSMC were then washed and incubated with antibodies conjugated to a fluorescent 
probe (FITC-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology, USA), 1:200 for 
30minutes at room temperature. In control experiments, the primary antibodies were pre-
incubated for 12h at 4°C with antigenic peptide (1:25). After removing the unbound 
secondary antibodies by washing the preparations with PBS, imaging was performed using 
the fluorescence microscope (NiKon, TE2000). 
 
Statistical analysis 
All results are expressed as the mean±SEM of at least 3 independent experiments. Data were 
compared using two-tailed Student's t-test or ANOVA and Tukey's multiple comparisons post 
hoc test as appropriate. Two-sided p values less than 0.05 were considered significant. Where 
error bars do not appear on the figure, error was within the symbol size. 
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